February JC at MSF: Trial of M72/AS01e Vaccine

Despite significant progress in the global fight against TB, there are no major game changers on the horizon to take the world towards TB elimination. A safe and effective vaccine would definitely be one. Is the M72/AS01E vaccine candidate that missing component? The Gates Foundation certainly think so, as the Gates MRI has obtained the licence to develop it further from GSK. Join us to review the evidence behind this exciting dream.

Please join us at MSF on 19th February, 2020, to discuss the NEJM paper findings on this Vaccine. Full details can be found on the Upcoming Events Page.

 

Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s